Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Mabwell / 迈威生物

Explore full profile

STAR biologics OEM — therapeutic antibodies and ADCs from Zhangjiang

ChinaFounded 2017Biotech & Life Sciences
Valuation $1.58B Market cap · 2026
Revenue $50–100M Latest reported FY

About Mabwell / 迈威生物

Shanghai STAR-listed integrated biologics OEM (Mabwell / 迈威生物; STAR 688062) develops and commercializes therapeutic antibodies and antibody-drug conjugates spanning oncology and autoimmune indications, with discovery-to-commercial manufacturing anchored in Zhangjiang. Founded in 2017, the company operates GMP biologics manufacturing and a multi-asset clinical-to-commercial pipeline including marketed products and ADCs such as Nectin-4 and CDH17 programs. Mid-size China ADC leftover beyond Pack 42 RemeGen FIX and Duality clinical-stage softer / Bio-Thera employees-only thinner profiles on the same antibody-drug lane.

Source: Dealroom company data

At a glance

Status
Listed
Founded
2017
Headquarters
China
Listing
IPO 2022
Sector
Biotech & Life Sciences
Power Law
Colt$25–100M revenue

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

  • Shiyu Capital
  • Founder H Fund
  • Sincere Capital
  • Ruihua Holdings
  • Haurong Rongde Asset Management
  • Loyal Valley Capital
  • Oriental Fortune Capital
  • Huajin Capital

Talent

Book a demo to see the people
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown
Web traffic by country
9.4K monthly visits
across markets
🇨🇳 China47.9%
🇺🇸 United States23.4%
🇮🇳 India12.8%
🇯🇵 Japan10.6%
🇹🇼 Taiwan2.1%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Mabwell / 迈威生物 on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mabwell / 迈威生物 on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles